Inside this issue:
Who should not receive
the flu vaccine?
2
What are the symptoms
of the flu?
3
Whats available?
3
When to get vaccinated?
4
One or two shots need-
ed?
4
Egg Allergy Protocol
4
Flu and COVID-19
5
When will vaccines be
available?
6
Payment
6
COVID XBB Booster
Update
7
Beyfortus (nirsevimab)
8
Fall 2023 Vaccine Chart
10
The flu is an illness caused by a
virus. Like a cold, it attacks the
nose, throat, and lungs. The flu
can sometimes lead to other
problems like pneumonia, ear/
sinus problems, dehydration, and
worsening of asthma. For most of
us, the flu will go away in 1-2
weeks.
2023-2024 Flu Season Newsletter
How can I catch the flu?
The flu is easily passed from person to
person via direct contact or via airborne
pathogens (coughing and sneezing).
A person can also get the flu by touching
something with the flu virus on it and then
touching their mouth or nose.
Everyone is at risk for getting the flu, but for some people the flu can
cause serious illness. Those most at risk include:
All children aged 6 months to 5 years
All persons aged older than or equal to 50 years
Children and adolescents (aged 6 months to 18 years) who are receiving long-
term aspirin therapy
Women who will be pregnant during the influenza season
Adults and children who have lung (including asthma), heart (except high blood
pressure), kidney, liver, brain/nerve, blood, or metabolic disorders (including diabe-
tes mellitus)
Adults and children who have a weak immune system either due to illness or medi-
cation
Residents of nursing homes and other long-term-care facilities
Health care personnel
People exposed to at-risk people
What you need to know about the flu
Who is most at risk for getting the flu?
P
BLUE FISH
E D I A T R I C S
www.bluefishmd.com
It is best for everyone, including breastfeeding mothers, to receive the flu vaccine (save
those who have contraindications to receiving it, as listed below). In the event of a known flu
vaccine shortage, we may be mandated by the CDC to follow a prioritization plan.
Who should not receive the flu vaccine?
Who should NOT receive the flu vaccine?
People who SHOULD NOT get the flu vaccine:
Children younger than 6 months of age
People with severe, life-threatening allergies to any ingredient (ingredients may include
gelatin, antibiotics, or others) in a flu vaccine (other than egg proteins)
People who have had a severe allergic reaction to a dose of influenza vaccine should
not get that flu vaccine again and might not be able to receive other influenza vaccines if
they have ever had Guillain-Barré Syndrome (a severe paralyzing illness, also called
GBS)
People who SHOULD NOT get the nasal spray flu vaccine:
Children younger than 2 years old
Adults 50 years and older
People with a history of severe allergic reaction to any ingredient of the vaccine or to a
previous dose of any flu vaccine
Children 2 through 17 years old who are receiving aspirin- or salicylate-containing
medications
Children 2 through 4 years old who have asthma or who have had a history of wheezing
in the past 12 months
People with weakened immune systems (immunosuppression) from any cause
People who care for severely immunocompromised persons who require a protected
environment (or otherwise avoid contact with those persons for 7 days after getting the
nasal spray vaccine)
People without a spleen, or with a non-functioning spleen
Pregnant women
People with an active leak between the cerebrospinal fluid and the mouth, nose, ear, or
other place within the skull
People with cochlear implants
People who have taken flu antiviral drugs within a certain amount of time (48 hours for
oseltamivir and zanamivir, 5 days for peramivir, and 17 days for baloxavir)
In addition, the following medical conditions are precautions to the use of the nasal
spray flu vaccine:
Asthma in people 5 years and older
Other underlying medical conditions that can put people at higher risk of serious flu
complications including lung disease, heart disease (except isolated hypertension),
kidney disease (like diabetes), kidney or liver disorders, neurologic/neuromuscular, or
metabolic disorders
Moderate or severe acute illness with or without fever
Guillain-Barré Syndrome within 6 weeks following a previous dose of flu vaccine
Page 2
2023-2024 Flu Season Newsletter
See page 4 for children under 9
years of age to see how many
doses are needed this season.
Influenza (flu)
usually comes on
suddenly. In many
cases you can
pinpoint the hour
when symptoms
start.
Whats available?
Note: Children 6 months to younger than 9 years of age may need to receive
the vaccine twice, separated by at least 4 weeks. See page 4 for exact details.
Page 3
2023-2024 Flu Season Newsletter
The flu shot prevents
serious complications from
the flu in 70% to 90% of
young, healthy adults.
About 20-50% of
the U.S. population
gets the flu each
season
Flu viruses are constantly changing. The composition of U.S. flu vaccines is
reviewed annually by the U.S. Food and Drug Administration Vaccines and
Related Biological Products Advisory Committee and updated as needed to best
match the flu viruses research indicates will be most common during the
upcoming season. The 2023-2024 season U.S. flu vaccines will contain an
updated influenza A(H1N1)pdm09 component:
A/Victoria/4897/2022 (H1N1)pdm09-like virus for egg-based vaccines and
A/Wisconsin/67/2022 (H1N1)pdm09-like virus for cell-based or recombinant
vaccines.
How well flu vaccine works can depend in part on the match between the vaccine
viruses and circulating viruses. Preliminary estimates show that last season,
people who were vaccinated against flu were about 40% to 70% less likely to be
hospitalized because of flu illness or related complications.
In healthy children 2-8 years of age, the Advisory Committee on Immunization
Practices (ACIP) no longer recommends a preference for the intranasal spray flu
vaccine over the injectable flu vaccine as new data from more recent seasons
have not confirmed superior effectiveness of the intranasal vaccine. Both the
intranasal and injectable are equally recommended.
The most common signs of the flu include:
Fever
Headache and muscle ache
Fatigue
Cough
What are the symptoms of the flu?
Sore throat
Runny or stuffy nose
Vomiting or diarrhea (more common
in children)
It takes about two weeks for
the flu vaccine to be
effective.
Age Dose
6 months and older (Injectable) 0.5 ml injection vaccine regardless of age
2 years and older (Intranasal)
Same dosage regardless of age; limited
supply this year
If your child is 9 years or older, regardless of what flu immunizations have been
given in the past, they will only need ONE immunization this flu season.
If your child is under 9 years of age, they may need TWO immunizations this
year. See the chart below to assist you in knowing how many shots your child
will need this flu season.
If your child needs two flu vaccines this year, they should be spaced apart by a
minimum of 4 weeks (28 days). There is no deadline by which the 2
nd
flu vaccine
needs to be completed, but once the minimum 4 weeks has passed, the sooner
the better as your child will have optimal protection only after the 2
nd
immunization.
The Saturday flu clinics we are hosting at multiple Blue Fish locations are each
spaced two weeks apart. Should your child need two flu vaccines, please plan
accordingly. For example, if you attend Saturday flu clinic #1, come back for the
second shot at flu clinic #3, 4, 5 or 6 (sooner is ideal). Or f you attend Saturday
flu clinic #3, come back for the second shot at flu clinic #5 or 6 (sooner is ideal).
“Seasonal” influenza vaccines are
formulated to prevent annual flu.
2023-2024 Flu Season Newsletter
Page 4
One or Two Shots Needed?
Check out our website for
updates on our flu vaccine
availability!
www.bluefishmd.com
0 flu shots
before July 2023
1 flu shot
before July 2023
2 flu shots
before July 2023
Under 9
years of age
2 flu shots
needed
2 flu shots
needed
1 flu shot needed
9 years or
older
1 flu shot
needed
1 flu shot needed 1 flu shot needed
Egg Allergy Protocol (per CDC)
All children with egg allergy of any severity can receive influenza vaccine
without any additional precautions beyond those recommended for any
vaccine.
Yearly flu vaccination should begin in September or as soon as the vaccine is
available and continue throughout the influenza season, as late as March or
beyond. The timing and duration of influenza seasons vary.
While influenza outbreaks can happen as early as October, most of the time
influenza activity peaks in February or later. About 2 weeks after vaccination,
antibodies that provide protection against influenza virus infection develop in the
body.
When to get vaccinated?
Blue Fish Pediatrics– MEMORIAL ONLY
Page 5
Flu and COVID-19 (per CDC)
Can I get the flu shot and COVID vaccine at the same time?
Yes, you can get a COVID-19 vaccine and a flu vaccine at the same time. Even though both vaccines can be given at
the same visit, people should follow the recommended schedule for either vaccine: If you havent gotten your currently
recommended doses of COVID-19 vaccine, get a COVID-19 vaccine as soon as you can, and ideally get a flu vaccine
by the end of October.
Can I have flu and COVID-19 at the same time?
Yes. It is possible have flu, as well as other respiratory illnesses, and COVID-19 at the same time. Health experts are
still studying how common this can be. Some of the symptoms of flu and COVID-19 are similar, making it hard to tell
the difference between them based on symptoms alone. Diagnostic testing can help determine if you are sick with flu
or COVID-19.
Will a flu vaccine protect me against COVID-19?
While getting a flu vaccine will not protect against COVID-19, flu vaccination has many other important benefits. Flu
vaccines have been shown to reduce the risk of flu illness, hospitalization and death. Getting a flu vaccine this fall will
be more important than ever, not only to reduce your risk from flu but also to help conserve potentially scarce health
care resources.
Should a flu vaccine be given to someone with suspected or confirmed COVID-19?
No. Vaccination should be deferred (postponed) for people with suspected or confirmed COVID-19, regardless of
whether they have symptoms, until they have met the criteria to discontinue their isolation. While mild illness is not a
contraindication to flu vaccination, vaccination visits for these people should be postponed to avoid exposing
healthcare personnel and other patients to the virus that causes COVID-19. When scheduling or confirming
appointments for vaccination, patients should be instructed to notify the providers office or clinic in advance if they
currently have or develop any symptoms of COVID-19. Additionally, a prior infection with suspected or confirmed
COVID-19 or flu does not protect someone from future flu infections. The best way to prevent seasonal flu is to get
vaccinated every year.
2023-2024 Flu Season Newsletter
When will the vaccines be available?
During regular office hours (starting in September), the flu vaccine will be available at well visits
for all patients of Blue Fish Pediatrics / family members living in the same household
with patients younger than 6 months old. Flu vaccines will also be administered during sick
visits at their doctors recommendation.
To help accommodate our busy families, we have designated Saturday flu clinics. Unlike
previous years, any patient of Blue Fish, regardless of their home office, can attend any
of our Saturday flu clinics. Any Blue Fish patient or parent is eligible to receive the flu
vaccine on these specially designated Saturdays (see below for dates). Also eligible are any
family member(s) living in the same household with patients younger than 6 months old. For
those 65yrs and older, Blue Fish does NOT carry the high dose flu vaccine. On these
specially designated Saturdays, please use our bookafy system to schedule ahead for the flu
vaccine. The scheduling link will be available on our website, and sent out to the mailing list for
newsletter recipients.
The availability of certain flu products may be limited towards the end of the flu season.
Please visit our website for the 2023-2024 flu information page (online booking available
for flu clinics; link on our flu information page)
The intradermal flu vaccine will NOT be available at Blue Fish.
The recombinant flu vaccine will NOT be available at Blue Fish.
Payment
Please read the following carefully. Regrettably, the following explanation is complicated and beyond our control.
All parents (and family members who are not Blue Fish patients) receiving the flu vaccine will pay cash prices. If you would like to
receive the flu vaccine via your insurance, please arrange for your flu vaccine through your regular doctor.
Cash paying patients: The cost is $40 for injection and $40 for nasal vaccine. If VFC eligible and VFC flu vaccine is in stock, then the cost is
$13.75 for the administration fee.
Medicaid and CHIP: The vaccine is covered by your insurance as long as we have the VFC flu vaccine in stock. If we should run out of VFC
stock, you can pay the cash price for the vaccine.
Commercial Insurance: You will need to pay your copay for your insurance. Even if your copay is higher than what we charge our cash
paying patients, we are contractually obligated by the insurance carrier to charge you the full copay amount. Insurance companies are firm
concerning this matter. We apologize for this inconvenience, but we are contractually obligated to do so. You have the option of receiving the
flu vaccine elsewhere such as a grocery store or pharmacy for their cash price (as they are not contracted with your insurance company.)
2023 Flu Clinic Dates and Locations Hours
September 9 Cypress and Katy
8:00 AM to
1:00 PM
All Clinics
Cypress and Katy October 21
September 16 Memorial
Memorial, Woodlands,
Sienna
October 28
September 23 Cypress and Katy Cypress and Katy November 4
September 30 Memorial Memorial November 11
October 7 Cypress and Katy Cypress and Katy November 18
October 14 Memorial
Memorial, Woodlands,
Sienna
December 2
Page 6
2023-2024 Flu Season Newsletter
2023 COVID XBB Booster Update
An updated COVID booster from Pfizer, Moderna, and Novavax is expected to
be available mid-to-late September. It will be targeted to protect against newer
variants which will likely provide better protection from prominent variants
now circulating, which are descendants of an omicron subvariant known as
XBB1.5.
If youre in a low-risk category for COVID complications and you dont have
consistent interaction with high-risk family or friends, waiting for the updated
booster is probably the best recommendation. However, it is a highly
individualized decision as there is not good data regarding this.
The updated booster expected for the fall season is showing a significant
boost in antibodies against many of the currently circulating variants.
There may be specific situations where you may want to play it safe and get
the current omicron COVID immunization now, if you have not already. If you
think youre going to have considerable exposures, between then and now, it
is recommended to be up to date with current COVID vaccines. The best time
to get vaccinated is before you get infected. You can always do another
COVID booster when the newer version is released.
If your child is 6 months to 4 years, they will need 3 total doses of the COVID
vaccine for full protection (#1 now, three weeks later #2, eight weeks later #3).
For this age group, in order not to delay protection, we recommend to begin
with the current COVID vaccine at this time and switch to the newer booster to
complete the series should it become available.
It is safe and effective to receive both the COVID and flu vaccines at the same
visit.
Our initial Saturday Flu Clinics will only offer the flu vaccine. However,
when the newest COVID booster becomes available we will offer it
alongside the flu vaccine at all remaining Saturday Flu Clinics and
at all Well Child Checks.
Blue Fish will likely only offer the Pfizer brand COVID booster.
Page 7
2023-2024 Flu Season Newsletter
What is Beyfortus (nirsevimab)?
Beyfortus(nirsevimab) is a new prescription long-acting monoclonal antibody product used to help prevent a serious
lung disease caused by Respiratory Syncytial Virus (RSV). Nirsevimab is not a vaccine.
Nirsevimab was approved by the US Food and Drug Administration (FDA) on July 17, 2023.
On August 3, 2023, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease
Control and Prevention (CDC) voted unanimously in favor of recommending use of nirsevimab.
The American Academy of Pediatrics recommends that all infants -- and especially those at high risk -- receive
the new preventive antibody, nirsevimab, to protect against severe disease caused by respiratory syncytial virus
(RSV), which is common, highly contagious and sometimes deadly.
RSV is one of the most common causes of childhood respiratory illness and results in annual outbreaks of respiratory
illnesses in all age groups. An estimated 58,000 to 80,000 children under 5 years of age, most of them infants, are
hospitalized each year nationwide due to RSV infection, with some requiring oxygen, intravenous (IV) fluids, or
mechanical ventilation (a machine to help with breathing). Each year, an estimated 100 to 300 children younger than
5 years of age die due to RSV.
Who should get Beyfortus (nirsevimab)?
Nirsevimab is recommended for:
1. All infants younger than 8 months born during or entering their first RSV season, including those recommended by
the American Academy of Pediatrics (AAP) to receive Synagis (palivizumab).
2. Infants and children aged 8 through 19 months who are at increased risk of severe RSV disease (see below) and
entering their second RSV season, including those recommended by the AAP to receive Synagis (palivizumab).
Per the FDA label, children who have received nirsevimab should not receive palivizumab for the same RSV season.
Who should not get nirsevimab?
Nirseveimab is contraindicated in individuals with a history of serious hypersensitivity reactions, including anaphylaxis, to
nirsevimab-alip or to any of the excipients.
Hypersensitivity including Anaphylaxis:
Serious hypersensitivity reactions, including anaphylaxis, have been observed rarely with other human IgG1 monoclonal
antibodies. If signs and symptoms of a clinically significant hypersensitivity reaction or anaphylaxis occur, initiate
appropriate medicinal products and/or supportive therapy.
Use in Individuals with Clinically Significant Bleeding Disorders:
As with any other IM injections, Beyfortus should be given with caution to individuals with thrombocytopenia, any
coagulation disorder or to individuals on anticoagulation therapy.
Nirsevimab is not recommended if there is a previous history of RSV infection.
Administration:
Prefilled syringe given IM in the thigh.
Reactions:
Most common adverse reactions with nirsevimab were rash (0.9%) and injection site reactions (0.3%).
Beyfortus (nirsevimab)
Page 8
2023-2024 Flu Season Newsletter
Pricing:
Estimated to be approximately $495 out of pocket. As soon as nirsevimab is available, Blue Fish hopes to have it in
stock. It will likely not be covered by insurances initially, but we will offer it for those families who qualify medically.
Parents can opt to pay for the treatment up front. (Insurances will be billed and reimbursement will be given should your
insurance later pay.)
For qualifying families, Beyfortus should be added to the VFC program sometime this fall, hopefully by October.
Timing of nirsevimab:
On the basis of pre-pandemic RSV infection patterns, nirsevimab may be administered in most of the continental United
States from October through the end of March.
Children 8 through 19 months of age who are recommended to receive nirsevimab when entering their SECOND
RSV season because of increased risk of severe disease:
1. Children with chronic lung disease of prematurity who required medical support (chronic corticosteroid therapy,
diuretic therapy, or supplemental oxygen) any time during the 6-month period before the start of the second RSV
season
2. Children who are severely immunocompromised
3. Children with cystic fibrosis who have manifestations of severe lung disease (previous hospitalization for pulmonary
exacerbation in the first year of life or abnormalities on chest imaging that persist when stable) or have weight-for-
length that is <10th percentile
Coadministration with routine childhood vaccines:
In accordance with the CDCs general best practices for immunizations, simultaneous administration of nirsevimab with
age-appropriate vaccines is recommended. In clinical trials, when nirsevimab was administered concomitantly with
routine childhood vaccines, the safety and reactogenicity profile of the concomitantly administered regimen was similar
to the childhood vaccines administered alone. When concomitantly administered, nirsevimab is not expected to interfere
with the immune response to other vaccines.
Page 9
Beyfortus (nirsevimab) continued
2023-2024 Flu Season Newsletter
Page 10
2023-2024 Flu Season Newsletter